Drug Safety Executive Council™ to Participate in Session at Society of Toxicology Annual Meeting

Share Article

Dr. Ernie Bush, Director of Collaborative Projects, will participate in panel on Searching for Drug Safety, Efficacy and Performance: Scientific and Regulatory Perspectives

News Image

The Drug Safety Executive Council™ (DSEC™) is pleased to announce that Dr. Ernie Bush, Director of Collaborative Projects, will participate in an interactive, audience driven session, Searching for Drug Safety, Efficacy and Performance: Scientific and Regulatory Perspectives, at the Society of Toxicology Annual Meeting.

A panel of industry experts will discuss critical industry and FDA needs for new ways to detect toxicity signals, efficacy trends and performance of drug candidates across studies, reports, chemical structures and other artifacts.

The session is sponsored by PointCross Life Sciences and will take place on Tuesday, March 13 at 11:00 a.m. in Room 101 Moscone Center. Refreshments will be provided.

About DSEC
The Drug Safety Executive Council™ (DSEC™) is an online community focused on the development of better and safer medicines. DSEC is a platform for biopharmaceutical companies, contract research organizations, government and academic institutions to share knowledge and exchange ideas on improving the drug safety assessment. Visit http://www.drugsafetycouncil.org.

About PointCross Life Sciences, Inc.
PointCross Life Sciences, Inc. is a global technology provider supporting drug safety development through a suite of information management repository offerings. These include safety biomarker detection and analytics, data validation, regulatory reviews and submissions support, and study data conversions and services. Clients encompass BioPharma companies around the globe, as well as the FDA. PointCross Life Sciences is a wholly owned subsidiary of PointCross, Inc.

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Alison Serrano

Dr. Shree Nath

Media